SOURCE-LINKED INTELLIGENCE

Spatially structured chip-based cognition platform for molecular mapping and therapy induced neurocognitive dysfunction modelling in pediatric medulloblastoma.

CORDIS · observation · Publication date unknown

ellular and molecular alterations across cognitive circuits. Spatial proteomic analysis through advanced multiplex imaging will reveal protein-level signatures of neurodevelopmental disruption, while Artificial Intelligence-driven analysis will model spatiotemporal patterns of injury and predict long-term impact on cognition. The combined approach of organoid biology, chip engineering, and computational modeling will generate a multidimensional understanding of therapy-driven changes. SCOPE is fully aligned with the Marie Skłodowska-Curie Actions (MSCA) work program by tackling the urgent challenge of protecting neurocognitive health in pediatric cancer survivors. It will train the fellow in organoid culture, microfluidics, proteomics, imaging, and AI-based systems biology, providing strong interdisciplinary expertise. Beyond advancing mechanistic insights, SCOPE establishes a developmentally relevant preclinical platform that strengthens EU research capacity, supports translational innovation in pediatric oncology, and contributes to reducing treatment-related disability in childre

Read original source ↗ Open in workspace

recordType

award

status

SIGNED

region

EU

value

252728.64

unit

EUR